Feb. 25, 2013 — The United States Food and Drug Administration (FDA) has approved generic versions of Reckitt Benckiser Healthcare’s Suboxone sublingual tablets. Buprenorphine HCl and Naloxone HCl Dihydrate SL Tablets, 2 mg/0.5 mg and 8 mg/2 mg… (Source: Drugs.com – Pharma News)
FDA Approves Generic Suboxone
Call 1 (888) 460-6556 to speak with a counselor.
Previous post: FDA Permits Production Of Generic Heroin Drug Against Bid Of Reckitt
Next post: Reckitt Benckiser hit by generic ruling